Rising Demand for Cost-Efficient Solutions Set to Expand Global Smart Hospital Market: WiseGuyReports

NEXT STORY
Atara Biotherapeutics Announces Collaborator Presentation Updating Positive Phase 1 Clinical Results for a Mesothelin-Targeted CAR T Immunotherapy in Patients with Advanced Mesothelioma
PREV STORY
BeiGene Chief Executive Officer John V. Oyler Elected to BIO Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BeiGene Announces Initiation of Pivotal Study in China with BTK Inhibitor BGB-3111 in Patients with Relapsed or Refractory CLL/SLL

BEIJING, March 09, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company ...

author_avatar
NASDAQ Market News

Spero Therapeutics to Present New Data for SPR994 and SPR206 at ESCMID/ASM 2018 Conference

Highlights include eleven presentations covering SPR994’s pharmacokinetics and pharmacodynamics, SPR206’s broad spectrum of activity ...

author_avatar
NASDAQ Market News

TESARO Announces Participation in Two Investor Conferences

WALTHAM, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

author_avatar
NASDAQ Market News